Microbot Medical (MBOT) Competitors

$1.76 +0.02 (+0.86%)

As of 02:51 PM Eastern

MBOT vs. SIBN, MDXG, KIDS, BBNX, and DCTH

Should you buy Microbot Medical stock or one of its competitors? MarketBeat compares Microbot Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Microbot Medical include SiBone (SIBN), MiMedx Group (MDXG), OrthoPediatrics (KIDS), Beta Bionics (BBNX), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry.

How does Microbot Medical compare to SiBone?

Microbot Medical (NASDAQ:MBOT) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Microbot Medical currently has a consensus price target of $7.50, suggesting a potential upside of 327.35%. SiBone has a consensus price target of $23.00, suggesting a potential upside of 54.47%. Given Microbot Medical's higher probable upside, analysts plainly believe Microbot Medical is more favorable than SiBone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

In the previous week, Microbot Medical had 5 more articles in the media than SiBone. MarketBeat recorded 9 mentions for Microbot Medical and 4 mentions for SiBone. Microbot Medical's average media sentiment score of 0.47 beat SiBone's score of 0.11 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SiBone	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Microbot Medical has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market. Comparatively, SiBone has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

Microbot Medical has higher earnings, but lower revenue than SiBone. SiBone is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
SiBone	$200.93M	3.29	-$18.90M	-$0.39	N/A

Microbot Medical has a net margin of 0.00% compared to SiBone's net margin of -8.10%. SiBone's return on equity of -9.56% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
SiBone	-8.10%	-9.56%	-7.06%

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Comparatively, 4.0% of SiBone shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Microbot Medical beats SiBone on 10 of the 16 factors compared between the two stocks.

How does Microbot Medical compare to MiMedx Group?

MiMedx Group (NASDAQ:MDXG) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

MiMedx Group has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.06, indicating that its stock price is 6% more volatile than the broader market.

MiMedx Group presently has a consensus target price of $8.50, suggesting a potential upside of 132.56%. Microbot Medical has a consensus target price of $7.50, suggesting a potential upside of 327.35%. Given Microbot Medical's higher possible upside, analysts clearly believe Microbot Medical is more favorable than MiMedx Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiMedx Group	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

MiMedx Group has a net margin of 7.88% compared to Microbot Medical's net margin of 0.00%. MiMedx Group's return on equity of 21.03% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiMedx Group	7.88%	21.03%	15.92%
Microbot Medical	N/A	-21.84%	-20.71%

MiMedx Group has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiMedx Group	$389.42M	1.40	$48.58M	$0.20	18.28
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

In the previous week, Microbot Medical had 5 more articles in the media than MiMedx Group. MarketBeat recorded 9 mentions for Microbot Medical and 4 mentions for MiMedx Group. Microbot Medical's average media sentiment score of 0.47 beat MiMedx Group's score of 0.15 indicating that Microbot Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiMedx Group	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Microbot Medical	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

79.2% of MiMedx Group shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 2.5% of MiMedx Group shares are held by company insiders. Comparatively, 4.7% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

MiMedx Group beats Microbot Medical on 11 of the 16 factors compared between the two stocks.

How does Microbot Medical compare to OrthoPediatrics?

OrthoPediatrics (NASDAQ:KIDS) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.

Microbot Medical has a net margin of 0.00% compared to OrthoPediatrics' net margin of -16.31%. OrthoPediatrics' return on equity of -7.01% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-16.31%	-7.01%	-4.86%
Microbot Medical	N/A	-21.84%	-20.71%

Microbot Medical has lower revenue, but higher earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.01	-$39.65M	-$1.68	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

In the previous week, Microbot Medical had 8 more articles in the media than OrthoPediatrics. MarketBeat recorded 9 mentions for Microbot Medical and 1 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.57 beat Microbot Medical's score of 0.47 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Microbot Medical	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

69.1% of OrthoPediatrics shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 32.7% of OrthoPediatrics shares are held by company insiders. Comparatively, 4.7% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

OrthoPediatrics has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.06, indicating that its stock price is 6% more volatile than the broader market.

OrthoPediatrics currently has a consensus price target of $24.44, indicating a potential upside of 31.96%. Microbot Medical has a consensus price target of $7.50, indicating a potential upside of 327.35%. Given Microbot Medical's higher possible upside, analysts plainly believe Microbot Medical is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

Summary

OrthoPediatrics beats Microbot Medical on 8 of the 15 factors compared between the two stocks.

How does Microbot Medical compare to Beta Bionics?

Microbot Medical (NASDAQ:MBOT) and Beta Bionics (NASDAQ:BBNX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

Microbot Medical has a net margin of 0.00% compared to Beta Bionics' net margin of -60.27%. Microbot Medical's return on equity of -21.84% beat Beta Bionics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
Beta Bionics	-60.27%	-23.00%	-20.55%

Microbot Medical currently has a consensus target price of $7.50, indicating a potential upside of 327.35%. Beta Bionics has a consensus target price of $20.00, indicating a potential upside of 89.93%. Given Microbot Medical's higher probable upside, analysts plainly believe Microbot Medical is more favorable than Beta Bionics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Beta Bionics	1 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.67

16.3% of Microbot Medical shares are owned by institutional investors. 4.7% of Microbot Medical shares are owned by company insiders. Comparatively, 5.3% of Beta Bionics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Microbot Medical has a beta of 1.06, meaning that its stock price is 6% more volatile than the broader market. Comparatively, Beta Bionics has a beta of 3.29, meaning that its stock price is 229% more volatile than the broader market.

In the previous week, Microbot Medical had 6 more articles in the media than Beta Bionics. MarketBeat recorded 9 mentions for Microbot Medical and 3 mentions for Beta Bionics. Microbot Medical's average media sentiment score of 0.47 beat Beta Bionics' score of -0.45 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Beta Bionics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Microbot Medical has higher earnings, but lower revenue than Beta Bionics. Beta Bionics is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
Beta Bionics	$110.24M	4.26	-$73.20M	-$1.51	N/A

Summary

Microbot Medical beats Beta Bionics on 9 of the 15 factors compared between the two stocks.

How does Microbot Medical compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

Delcath Systems has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market.

Delcath Systems currently has a consensus price target of $22.50, suggesting a potential upside of 95.89%. Microbot Medical has a consensus price target of $7.50, suggesting a potential upside of 327.35%. Given Microbot Medical's stronger consensus rating and higher possible upside, analysts plainly believe Microbot Medical is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

Delcath Systems has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	4.65	$2.70M	$0.01	1,148.60
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

Delcath Systems has a net margin of 0.62% compared to Microbot Medical's net margin of 0.00%. Delcath Systems' return on equity of 0.51% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Microbot Medical	N/A	-21.84%	-20.71%

61.1% of Delcath Systems shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by company insiders. Comparatively, 4.7% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Microbot Medical had 6 more articles in the media than Delcath Systems. MarketBeat recorded 9 mentions for Microbot Medical and 3 mentions for Delcath Systems. Microbot Medical's average media sentiment score of 0.47 beat Delcath Systems' score of 0.17 indicating that Microbot Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Microbot Medical	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Delcath Systems beats Microbot Medical on 10 of the 16 factors compared between the two stocks.

Get Microbot Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MBOT vs. The Competition

Export

Metric	Microbot Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$117.88M	$6.98B	$6.33B	$12.33B
Dividend Yield	N/A	1.70%	2.80%	5.36%
P/E Ratio	-6.75	50.13	20.88	25.51
Price / Sales	N/A	72.78	520.50	73.06
Price / Cash	N/A	24.40	43.18	55.00
Price / Book	1.60	6.51	10.01	7.03
Net Income	-$13.14M	$158.81M	$3.54B	$334.92M
7 Day Performance	-5.14%	2.03%	0.38%	-0.40%
1 Month Performance	-18.37%	-0.94%	-0.02%	1.07%
1 Year Performance	-30.91%	2.04%	35.07%	34.65%

Microbot Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MBOT Microbot Medical	2.5502 of 5 stars	$1.76 +0.9%	$7.50 +327.4%	-33.6%	$117.88M	N/A	N/A	20
SIBN SiBone	2.5932 of 5 stars	$11.61 -5.4%	$24.00 +106.7%	-24.8%	$542.87M	$200.93M	N/A	350	Insider Trade High Trading Volume
MDXG MiMedx Group	3.7963 of 5 stars	$3.56 -1.1%	$8.50 +138.8%	-47.1%	$536.21M	$418.63M	17.80	870	Analyst Downgrade
KIDS OrthoPediatrics	3.7197 of 5 stars	$17.18 -3.5%	$24.44 +42.3%	-19.2%	$457.45M	$236.35M	N/A	200
BBNX Beta Bionics	3.1344 of 5 stars	$9.85 +2.1%	$22.00 +123.4%	-36.2%	$430.02M	$100.25M	N/A	294	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MBOT) was last updated on 5/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Microbot Medical (MBOT) Competitors

MBOT vs. SIBN, MDXG, KIDS, BBNX, and DCTH

How does Microbot Medical compare to SiBone?

Summary

How does Microbot Medical compare to MiMedx Group?

Summary

How does Microbot Medical compare to OrthoPediatrics?

Summary

How does Microbot Medical compare to Beta Bionics?

Summary

How does Microbot Medical compare to Delcath Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT vs. The Competition

Microbot Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Microbot Medical (MBOT) Competitors

MBOT vs. SIBN, MDXG, KIDS, BBNX, and DCTH

How does Microbot Medical compare to SiBone?

Do analysts rate MBOT or SIBN?

Does the media favor MBOT or SIBN?

Which has more volatility & risk, MBOT or SIBN?

Which has preferable valuation and earnings, MBOT or SIBN?

Is MBOT or SIBN more profitable?

Do insiders and institutionals hold more shares of MBOT or SIBN?

Summary

How does Microbot Medical compare to MiMedx Group?

Which has more risk and volatility, MDXG or MBOT?

Do analysts rate MDXG or MBOT?

Is MDXG or MBOT more profitable?

Which has stronger earnings & valuation, MDXG or MBOT?

Does the media favor MDXG or MBOT?

Do insiders & institutionals hold more shares of MDXG or MBOT?

Summary

How does Microbot Medical compare to OrthoPediatrics?

Is KIDS or MBOT more profitable?

Which has preferable earnings and valuation, KIDS or MBOT?

Does the media refer more to KIDS or MBOT?

Do insiders and institutionals have more ownership in KIDS or MBOT?

Which has more risk and volatility, KIDS or MBOT?

Do analysts prefer KIDS or MBOT?

Summary

How does Microbot Medical compare to Beta Bionics?

Is MBOT or BBNX more profitable?

Do analysts recommend MBOT or BBNX?

Do institutionals & insiders have more ownership in MBOT or BBNX?

Which has more volatility & risk, MBOT or BBNX?

Does the media prefer MBOT or BBNX?

Which has better valuation & earnings, MBOT or BBNX?

Summary

How does Microbot Medical compare to Delcath Systems?

Which has more volatility and risk, DCTH or MBOT?

Do analysts recommend DCTH or MBOT?

Which has stronger valuation and earnings, DCTH or MBOT?

Is DCTH or MBOT more profitable?

Do institutionals and insiders hold more shares of DCTH or MBOT?

Does the media favor DCTH or MBOT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT vs. The Competition

Microbot Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools